A detailed history of Dearborn Partners LLC transactions in Danaher Corp stock. As of the latest transaction made, Dearborn Partners LLC holds 1,071 shares of DHR stock, worth $251,738. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,071
Previous 1,071 -0.0%
Holding current value
$251,738
Previous $267,000 11.24%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$235.51 - $267.98 $21,195 - $24,118
90 Added 9.17%
1,071 $267,000
Q1 2024

May 08, 2024

SELL
$224.58 - $256.19 $12,351 - $14,090
-55 Reduced 5.31%
981 $244,000
Q3 2023

Nov 01, 2023

SELL
$233.08 - $265.59 $42,420 - $48,337
-182 Reduced 14.94%
1,036 $257,000
Q2 2023

Aug 03, 2023

BUY
$224.99 - $256.14 $8,549 - $9,733
38 Added 3.22%
1,218 $292,000
Q1 2023

May 04, 2023

SELL
$239.75 - $277.0 $182,449 - $210,797
-761 Reduced 39.21%
1,180 $297,000
Q4 2022

Feb 02, 2023

BUY
$241.42 - $282.29 $70,253 - $82,146
291 Added 17.64%
1,941 $515,000
Q3 2022

Oct 25, 2022

BUY
$247.06 - $1507.4 $43,729 - $266,809
177 Added 12.02%
1,650 $426,000
Q1 2022

May 04, 2022

SELL
$257.27 - $315.76 $2,315 - $2,841
-9 Reduced 0.61%
1,473 $432,000
Q3 2021

Oct 27, 2021

BUY
$272.21 - $332.43 $1,361 - $1,662
5 Added 0.34%
1,482 $451,000
Q2 2021

Jul 26, 2021

SELL
$225.08 - $271.69 $4,951 - $5,977
-22 Reduced 1.47%
1,477 $396,000
Q4 2020

Jan 27, 2021

SELL
$212.5 - $245.46 $10,625 - $12,273
-50 Reduced 3.23%
1,499 $333,000
Q3 2020

Oct 20, 2020

BUY
$177.16 - $215.33 $708 - $861
4 Added 0.26%
1,549 $334,000
Q2 2020

Jul 30, 2020

SELL
$128.7 - $176.83 $4,504 - $6,189
-35 Reduced 2.22%
1,545 $273,000
Q1 2019

May 01, 2019

BUY
$97.62 - $132.29 $154,239 - $209,018
1,580 New
1,580 $209,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Dearborn Partners LLC Portfolio

Follow Dearborn Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dearborn Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dearborn Partners LLC with notifications on news.